Genocea Biosciences Inc Acciones en circulación
¿Qué es el Acciones en circulación de Genocea Biosciences Inc?
El Acciones en circulación de Genocea Biosciences Inc es 58.784M
¿Cuál es la definición de Acciones en circulación?
Las acciones en circulación son todas las acciones de una corporación o de un activo financiero que han sido autorizadas, emitidas y compradas por los inversionistas y son retenidas por ellos.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Acciones en circulación de compañías en Sector Health Care en NASDAQ en comparadas con Genocea Biosciences Inc
¿Qué hace Genocea Biosciences Inc?
Genocea's mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types. Our unique ATLAS™ platform comprehensively profiles each patient's T cell responses to potential targets, or antigens, on the tumor. ATLAS enables us to optimize the neoantigens for inclusion in our immunotherapies and exclude inhibitory antigens, Inhibigens™, that can exert an immunosuppressive effect. We are advancing two ATLAS-enabled programs: GEN-009, our neoantigen vaccine and GEN-011, our neoantigen-specific cell therapy using T cells derived from peripheral blood.
Empresas con acciones en circulación similar a Genocea Biosciences Inc
- IOL Chemicals and Pharmaceuticals tiene Acciones en circulación de 58.706M
- IOL Chemicals and Pharmaceuticals tiene Acciones en circulación de 58.706M
- Invesco Asia Trust Plc tiene Acciones en circulación de 58.707M
- Cyon Exploration tiene Acciones en circulación de 58.725M
- Teleperformance SE tiene Acciones en circulación de 58.733M
- Clifton Mining Co tiene Acciones en circulación de 58.771M
- Genocea Biosciences Inc tiene Acciones en circulación de 58.784M
- Jiulian Resources tiene Acciones en circulación de 58.787M
- B.C. Power Controls tiene Acciones en circulación de 58.800M
- B.C. Power Controls tiene Acciones en circulación de 58.800M
- Iliad SA tiene Acciones en circulación de 58.818M
- GTT Communications Inc tiene Acciones en circulación de 58.820M
- California Water Service tiene Acciones en circulación de 58.825M